Source: Annual Congress 2013 –Ceremony for the ERS Maurizio Vignola Award for Best Publication on Innovation in Pneumology (financially supported by Chiesi Foundation) followed by Hot Topic: Towards delivering personalised or precision medicine in respiratory healthcare



Rating:

Share or cite this content

Citations should be made in the following way:
P. J. Sterk (Amsterdam, The Netherlands). Application of 'omics to uncover novel disease pathways. Annual Congress 2013 –Ceremony for the ERS Maurizio Vignola Award for Best Publication on Innovation in Pneumology (financially supported by Chiesi Foundation) followed by Hot Topic: Towards delivering personalised or precision medicine in respiratory healthcare

Member's Comments

No comment yet.

Related content which might interest you: Application of ’omics technologies to biomarker discovery in inflammatory lung diseases Source: Eur Respir J 2013; 42: 802-825 Year: 2013 The omics approach to defining endotypes and personalising treatment pathways in asthma Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease Year: 2016 U-BIOPRED accessible handprint: combining omics platforms to identify stable asthma subphenotypes Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018 Integration of transcriptomics and metabolomics with microbiomic data to identify host-microbiota interactions Source: International Congress 2019 – PG16 Assessment and analysis of the lung microbiome Year: 2019 Personal ‘omics profiling Source: ERS Lung Science Conference 2016 Year: 2016 High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications Source: Eur Respir J 2009; 33: 489-506 Year: 2009 COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Scene-setting: why do we need genomics and proteomics to understand pathology? Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease Year: 2004 Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema Source: ERS Lung Science Conference 2016 Year: 2016 Integration of multi-omics datasets enables molecular classification of COPD Source: Eur Respir J, 51 (5) 1701930; 10.1183/13993003.01930-2017 Year: 2018 LSC Abstract – Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 Integration at the network- and pathway level of multi-omics data from multiple anatomical locations facilitate COPD sub-phenotyping in small cohorts Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 A multi-omics data integration approach to identify a predictive molecular signature of CLAD Source: International Congress 2015 – Predictors of lung transplant complications Year: 2015 High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Late Breaking Abstract - Early exploratory use of omic approaches to assess metabolite changes in COPD Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers Year: 2020 Integrative clustering analysis to discover novel IPF disease subtypes in the IPF-PRO Registry Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 Non-targeted integrative multi-omics approaches on sputum reveal potential diagnostic and monitoring biomarkers for respiratory diseases Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017